Prospects for controlling future pandemics of influenza

被引:16
作者
Robertson, James S. [1 ]
Inglis, Stephen C. [1 ]
机构
[1] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
关键词
Influenza; Vaccine; Anti-virals; Pandemics; Surveillance; Pandemic preparedness; CANDIDATE VACCINE VIRUSES; REVERSE GENETICS; A VIRUS; HEMAGGLUTININ; CELLS; IMMUNOGENICITY; EVENT;
D O I
10.1016/j.virusres.2011.09.024
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pandemic influenza remains one of the most serious threats to global public health and continued global vigilance to monitor emerging threats is crucial. Of the weapons available to control a pandemic, vaccination is potentially the most powerful, but there are currently serious limitations to timely availability of vaccine supply in an emergency. Many novel influenza vaccines are in development, some of which have the potential to deliver the massive quantities of vaccine that would be required in a pandemic in a short period of time. However, for the foreseeable future, it is likely that the principal vaccine that will be deployed in a pandemic will be an inactivated egg-derived vaccine of the kind that has been available for several decades. This review will focus on the practical hurdles that need to be surmounted to deliver large amounts of safe and effective pandemic vaccine to the general public. There needs to be a continued focus on improvement to the vaccine response system that will require close collaboration between influenza and vaccine experts, manufacturers, regulators and public health authorities around the world. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 50 条
[21]   Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022 [J].
Romeo, Roberto ;
Legnani, Laura ;
Chiacchio, Maria Assunta ;
Giofre, Salvatore V. ;
Iannazzo, Daniela .
CURRENT MEDICINAL CHEMISTRY, 2024, 31 (18) :2507-2549
[22]   Prospects and Challenges in the Development of Universal Influenza Vaccines [J].
Madsen, Anders ;
Cox, Rebecca Jane .
VACCINES, 2020, 8 (03) :1-12
[23]   A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics [J].
Fabrice Carrat ;
Julie Luong ;
Hervé Lao ;
Anne-Violaine Sallé ;
Christian Lajaunie ;
Hans Wackernagel .
BMC Medicine, 4
[24]   The Psychology of Pandemics: Lessons Learned for the Future [J].
Taylor, Steven .
CANADIAN PSYCHOLOGY-PSYCHOLOGIE CANADIENNE, 2022, 63 (02) :233-246
[25]   Controlling pandemic influenza through vaccination programs [J].
Sahni, Rajiv ;
Mossad, Sherif B. .
FUTURE VIROLOGY, 2009, 4 (03) :271-276
[26]   Genetic immunity and influenza pandemics [J].
Rumyantsev, Sergey N. .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2006, 48 (01) :1-10
[27]   Experience with the clinical development of influenza vaccines for potential pandemics [J].
Wood, JM ;
Nicholson, KG ;
Stephenson, I ;
Zambon, M ;
Newman, RW ;
Major, DL ;
Podda, A .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (3-4) :197-201
[28]   Simplifying Influenza Vaccination During Pandemics: Sublingual Priming and Intramuscular Boosting of Immune Responses with Heterologous Whole Inactivated Influenza Vaccine [J].
Murugappan, Senthil ;
Patil, Harshad P. ;
Frijlink, Henderik W. ;
Huckriede, Anke ;
Hinrichs, Wouter L. J. .
AAPS JOURNAL, 2014, 16 (02) :342-349
[29]   History and future of pandemics [J].
Angel Sanchez-Gonzalez, Miguel .
REVISTA MEDICA CLINICA LAS CONDES, 2021, 32 (01) :7-13
[30]   The WHO global influenza surveillance and response system (GISRS)A future perspective [J].
Hay, Alan J. ;
McCauley, John W. .
INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2018, 12 (05) :551-557